Medicare Enrolled
Dr. Denise Taylor, D.O.
Neurology · Athens, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taylor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taylor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taylor
Dr. Denise Taylor is a neurology specialist in Athens, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Taylor performed 15,738 Medicare services across 853 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taylor received a total of $18,749 from 65 pharmaceutical and/or device companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 6% volume in GA
$18,749 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,738
Medicare services
Top 6% in GA for neurology
853
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~874 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
14,765 | $4 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $83 | $326 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
247 | $55 | $230 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $113 | $444 |
| New patient office visit, complex (60-74 min) | 78 | $141 | $537 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $129 | $436 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $132 | $464 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
37 | $110 | $872 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 35 | $46 | $200 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
29 | $115 | $703 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $91 | $220 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
17 | $139 | $2,000 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
17 | $245 | $1,250 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
11 | $42 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,749
Total received (2018-2024)
Avg $2,678/year across 7 years
Top 17% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
501
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,527 (50.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,271 (44.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$951 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,340
2023
$1,515
2022
$1,020
2021
$1,480
2020
$3,537
2019
$2,063
2018
$6,792
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$761
ABBVIE INC.
$179
CATALYST PHARMACEUTICALS, INC.
$171
Neurocrine Biosciences, Inc.
$134
SK Life Science, Inc.
$131
UCB, Inc.
$113
Eisai Inc.
$72
Lilly USA, LLC
$71
TG Therapeutics, Inc.
$67
Teva Pharmaceuticals USA, Inc.
$57
PFIZER INC.
$53
Lundbeck LLC
$51
Amgen Inc.
$49
Alexion Pharmaceuticals, Inc.
$43
HARMONY BIOSCIENCES LLC
$41
Octapharma USA, Inc.
$40
Takeda Pharmaceuticals U.S.A., Inc.
$35
Amneal Pharmaceuticals LLC
$31
Xeris Pharmaceuticals, Inc.
$25
Novartis Pharmaceuticals Corporation
$24
Marinus Pharmaceuticals, Inc.
$24
ARGENX US, INC.
$23
Neurelis, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$19
Vanda Pharmaceuticals Inc.
$18
Biogen, Inc.
$18
BANNER LIFE SCIENCES, LLC
$17
ACADIA Pharmaceuticals Inc
$16
Genentech USA, Inc.
$16
Resmed Corp
$14
Cycle Pharmaceuticals Inc
$6
Top 3 companies account for 47.5% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$10,937
Sunovion Pharmaceuticals Inc.
$796
LivaNova USA, Inc.
$761
SK Life Science, Inc.
$563
AbbVie Inc.
$544
ABBVIE INC.
$415
Alexion Pharmaceuticals, Inc.
$394
Novartis Pharmaceuticals Corporation
$332
Amgen Inc.
$289
Greenwich Biosciences, Inc.
$239
Teva Pharmaceuticals USA, Inc.
$232
Eisai Inc.
$214
Neurocrine Biosciences, Inc.
$199
Lilly USA, LLC
$194
CATALYST PHARMACEUTICALS, INC.
$171
EMD Serono, Inc.
$163
Biogen, Inc.
$152
MDD US Operations, LLC
$127
Neurelis, Inc.
$125
PFIZER INC.
$122
Lundbeck LLC
$122
ARGENX US, INC.
$108
Allergan Inc.
$107
GENZYME CORPORATION
$76
Horizon Therapeutics plc
$75
TG Therapeutics, Inc.
$67
CSL Behring
$66
Amneal Pharmaceuticals LLC
$58
ACADIA Pharmaceuticals Inc
$56
GE HEALTHCARE
$54
Mallinckrodt Hospital Products Inc.
$51
Marinus Pharmaceuticals, Inc.
$48
EISAI INC.
$48
AbbVie, Inc.
$45
Allergan, Inc.
$44
Avanir Pharmaceuticals, Inc.
$43
Catalyst Pharmaceuticals, Inc.
$43
Harmony Biosciences LLC
$41
HARMONY BIOSCIENCES LLC
$41
Sumitomo Pharma America, Inc.
$40
Octapharma USA, Inc.
$40
Xeris Pharmaceuticals, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$35
Janssen Pharmaceuticals, Inc
$35
US WorldMeds, LLC
$30
Biohaven Pharmaceuticals, Inc.
$28
TG THERAPEUTICS, INC.
$25
Acorda Therapeutics, Inc
$24
MERZ NORTH AMERICA, INC.
$23
Jazz Pharmaceuticals Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
ANI Pharmaceuticals, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
SCILEX PHARMACEUTICALS INC.
$19
IMPEL PHARMACEUTICALS INC.
$18
Vanda Pharmaceuticals Inc.
$18
BANNER LIFE SCIENCES, LLC
$17
Upsher-Smith Laboratories LLC
$17
Adamas Pharmaceuticals, Inc.
$16
Genentech USA, Inc.
$16
UPSHER-SMITH LABORATORIES LLC
$16
Resmed Corp
$14
Impax Laboratories, Inc.
$13
Zogenix Inc.
$13
Cycle Pharmaceuticals Inc
$6
Top 3 companies account for 66.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CREXONT · DAYBUE · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · NAMZARIC · NEXVIAZYME · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · ONPATTRO · Ocrevus · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · SOLIRIS · Soliris · TOSYMRA · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XCOPRI · XEOMIN · Xadago · ZEPOSIA · ZTALMY · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Neurologists within 10 mi
21
Per 100K population
16.2
County median income
$52,267
Nearest hospital
ST MARY'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taylor is a mixed practice specialist, with above-average Medicare volume (top 6% in GA), with speaking/promotional industry engagement in the top 17% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taylor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Taylor performed 14,765 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taylor receive payments from pharmaceutical companies?
Yes. Dr. Taylor received a total of $18,749 from 65 companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taylor's costs compare to other neurologists in Athens?
Dr. Taylor's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taylor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Athens
Browse neurologists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology